COMPOSITION OF AMINO-ACID INFUSIONS AND EFFECT OF CHOLECYSTOKININ ON INSULIN RELEASE IN DOGS

被引:0
作者
SCHMID, R [1 ]
SCHUSDZIARRA, V [1 ]
BUTSCHER, H [1 ]
CLASSEN, M [1 ]
机构
[1] TECH UNIV MUNICH,DEPT INTERNAL MED 2,ISMANINGER STR 22,W-8000 MUNICH 2,GERMANY
关键词
CHOLECYSTOKININ; ENTEROINSULAR AXIS; AMINO ACIDS; INSULIN; GLUCAGON;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the present study we have examined if the different composition of intravenously administered amino acid solutions is of importance for the effect of cholecystokinin (CCK) on pancreatic insulin and glucagon release in dogs. In 6 conscious dogs CCK-9 was infused intravenously at stepwise increasing doses of 5, 10 and 20 pmol/kg.h during an intravenous background infusion of Aminosteril or Aminoplasmal. Aminosteril contains more insulinogenic amino acids while Aminoplasmal contains more glucagonogenic amino acids. CCK elicited a significant stimulation of insulin levels by 10-mu-U/ml (p < 0.01) in the presence of i.v. Aminosteril compared to that elicited by i.v. amino acids alone. Glucagon and glucose levels remained unchanged. During i.v. Aminoplasmal CCK-9 had no effect. Since in dogs the physiological plasma amino acid pattern following the ingestion of protein-rich meals is unknown the possibility cannot be excluded that in dogs CCK acts as a mediator of the intestinal signal which augments insulin release during ingestion of protein-rich meals.
引用
收藏
页码:244 / 249
页数:6
相关论文
共 19 条
[1]   EXOCRINE PANCREATIC-SECRETION IN RESPONSE TO A NEW CCK-ANALOG, CCK33 AND CERULEIN IN DOGS [J].
BEGLINGER, C ;
SOLOMON, TE ;
GYR, K ;
MORODER, L ;
WUNSCH, E .
REGULATORY PEPTIDES, 1984, 8 (04) :291-296
[2]  
Faloona G.R, 1974, METHOD HORM RADIOIMM, P317
[3]   EFFECTS OF OCTAPEPTIDE OF CHOLECYSTOKININ ON INSULIN AND GLUCAGON-SECRETION IN DOG [J].
FRAME, CM ;
DAVIDSON, MB ;
STURDEVANT, RAL .
ENDOCRINOLOGY, 1975, 97 (03) :549-553
[4]   COATED CHARCOAL IMMUNOASSAY OF INSULIN [J].
HERBERT, V ;
LAU, KS ;
GOTTLIEB, CW ;
BLEICHER, SJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1965, 25 (10) :1375-+
[6]   EFFECTS OF GASTRIN, GASTRIC INHIBITORY POLYPEPTIDE, SECRETIN, AND OCTAPEPTIDE OF CHOLECYSTOKININ UPON IMMUNOREACTIVE SOMATOSTATIN RELEASE BY PERFUSED CANINE PANCREAS [J].
IPP, E ;
DOBBS, RE ;
HARRIS, V ;
ARIMURA, A ;
VALE, W ;
UNGER, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (05) :1216-1219
[7]   STUDIES ON CHOLECYSTOKININ-PANKREOZYMIN - SYNTHESIS OF [28-THREONINE,31-NORLEUCINE] AND [28-THREONINE,31-LEUCINE]CHOLECYSTOKININ-PANKREOZYMIN-(25-33)-NONAPEPTIDE [J].
MORODER, L ;
WILSCHOWITZ, L ;
GEMEINER, M ;
GOHRING, W ;
KNOF, S ;
SCHARF, R ;
THAMM, P ;
GARDNER, JD ;
SOLOMON, TE ;
WUNSCH, E .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1981, 362 (07) :929-942
[8]  
REIMERS J, 1988, DIABETOLOGIA, V14, P271
[9]   GLUCAGON-STIMULATING ACTIVITY OF 20 AMINO-ACIDS IN DOGS [J].
ROCHA, DM ;
UNGER, RH ;
FALOONA, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (09) :2346-+
[10]   PHYSIOLOGICAL-ROLE OF CHOLECYSTOKININ IN MEAL-INDUCED INSULIN-SECRETION IN CONSCIOUS RATS - STUDIES WITH L-364718, A SPECIFIC INHIBITOR OF CCK-RECEPTOR BINDING [J].
ROSSETTI, L ;
SHULMAN, GI ;
ZAWALICH, WS .
DIABETES, 1987, 36 (10) :1212-1215